Cardiff Lexington Corp (CDIX) Stock Price & Analysis
Cardiff Lexington Corp (CDIX) rose 0.91% to USD 1.67 as of June 10, 2026 at 03:40 UTC, according to Nexqual real-time market data.
CDIX last closed at USD 1.65; the session ranged USD 1.5–1.8 on volume of 1,700 shares. Market capitalization is $25.45M, with a 52-week range of USD 0.93–14.25 (OQX). Source: Nexqual, June 10, 2026 at 03:40 UTC.
Key Statistics (as of June 10, 2026 at 03:40 UTC)
| Price | USD 1.67 |
|---|---|
| Change | ▲ 0.91% (up) |
| Previous Close | USD 1.65 |
| Open | USD 1.8 |
| Day Range | USD 1.5 – 1.8 |
| 52-Week Range | USD 0.93 – 14.25 |
| Volume | 1,700 shares |
| Market Cap | $25.45M |
| Exchange | OQX |
Technical Analysis (CDIX)
Nexqual's technical model rates CDIX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 47.64 (neutral) |
| vs SMA50 | Below (USD 1.92) |
| MACD | -0.1 (negative) |
Analyst Ratings (CDIX)
Wall Street analysts rate CDIX "None", per Nexqual as of June 10, 2026 at 03:40 UTC.
| Consensus Rating | None |
|---|
Earnings (CDIX)
Source: Nexqual, June 10, 2026 at 03:40 UTC.
Financials & Fundamentals (CDIX)
| Total Revenue | $10.84M |
|---|---|
| Revenue Growth (YoY) | -23.80% |
| Gross Margin | +61.65% |
| Operating Margin | -23.00% |
| Profit Margin | -75.16% |
| ROE | -131.46% |
| Debt / Equity | 364.63 |
| Current Ratio | 0.98 |
| Total Cash | $683,507 |
| Total Debt | $20.64M |
| Free Cash Flow | $-12.05M |
Source: Nexqual, June 10, 2026 at 03:40 UTC.
Financial Health Score (CDIX)
Nexqual rates Cardiff Lexington Corp's overall financial health "Critical" across five dimensions, as of June 10, 2026 at 03:40 UTC.
| Growth | Critical — Revenue -24% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $684K cash vs $21M debt |
| Cash Flow | Weak — FCF negative: -$12M, burning cash |
| Efficiency | Critical — ROE -131%, ROA 0.1% |
Ownership (CDIX)
| Insider Ownership | +61.97% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 15.28M |
| Float | 6.43M |
Source: Nexqual, June 10, 2026 at 03:40 UTC.
Leadership (CDIX)
Cardiff Lexington Corp is led by Alex Hunt Cunningham (age 69), CEO, President & Chairman of the Board, per Nexqual as of June 10, 2026 at 03:40 UTC.
| CEO, President & Chairman of the Board | Alex Hunt Cunningham (age 69) |
|---|---|
| Senior VP, CFO, Chief Accounting Officer & Treasurer | Matthew T. Shafer (age 54) |
| Managing Director of Nova Ortho & Spine | Kevin Fitzgerald |
From Cardiff Lexington Corp's Latest SEC 10-K Filing (filed 2026-03-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States.
- The company operates through two segments, Healthcare and Real Estate.
- The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves.
- The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BLTH | American Battery Materials Inc. | USD 5.25 | ▲ 5% |
| PACV | Pacific Ventures Group Inc. | USD 0 | ▲ 0% |
| AAPJ | AAP, Inc. | USD 0 | ▲ 0% |
| AMNC | Amincor Inc | USD 0.03 | ▲ 0% |
| SSOF | Sixty Six Oilfield Services, In | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:40 UTC. This page is informational and not investment advice.